Navigator SAP
JUNE 24, 2022
Legacy software systems no longer make sense for life sciences businesses, especially those in Pharmaceutical manufacturing. The problem is that complexity, regulation, and competition have changed how pharmaceutical and life sciences firms must do business. Data is siloed, hard to update, and time-consuming to store or use.
Navigator SAP
AUGUST 5, 2022
The pharmaceutical industry has been transformed in recent years by pressure from intensely competitive markets and the need to comply with new regulations that mandate the highest quality standards across all processes. As such, cloud ERP is critical for pharmaceutical operations today given this environment.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Navigator SAP
OCTOBER 14, 2022
It’s an uphill task for Contract Development and Manufacturer Organizations (CDMOs) to ensure product quality at the rapid pace demanded by customers, especially when they must deal with safety, control, and regulatory regimes in fields such as pharmaceuticals, biotech, and other areas of the life sciences.
Navigator SAP
SEPTEMBER 9, 2022
The pharmaceutical industry has undergone significant evolution within the past 15 years. Recently, biopharmaceutical companies have become increasingly reliant on outsourced contract services for various elements of their value chain.
Advertiser: GEP
Drawing on our work with global companies across manufacturing, automotive, pharmaceuticals, semiconductors, software, technology, financial services, and a range of service industries, we outline the key strategic and tactical actions companies are taking to navigate this period of heightened uncertainty.
Navigator SAP
SEPTEMBER 16, 2022
Contract development and manufacturing organizations (CDMOs) face unique challenges. They’re outsourced to handle drug and therapy development as well as to manufacture pharmaceutical, nutraceutical, and biological materials.
Navigator SAP
JUNE 9, 2023
When a pen is manufactured incorrectly or suffers from shoddy inputs, a consumer just pulls out a different pen. When a life sciences product deviates from specs, be it a pharmaceutical or medical device, public health is affected and the defect might not even be readily observable. The life sciences are not like pens or bras.
Expert insights. Personalized for you.
246 
Let's personalize your content